Antares Pharma, Inc.
(NASDAQ : ATRS)

( )
ATRS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.67%463.201.0%$800.74m
ABTAbbott Laboratories 0.30%122.580.8%$584.39m
MDTMedtronic Plc 0.07%117.940.6%$576.08m
DHRDanaher Corp. -0.77%223.930.7%$516.43m
BSXBoston Scientific Corp. -0.44%38.731.0%$411.57m
ISRGIntuitive Surgical, Inc. -1.21%750.002.3%$398.60m
ALGNAlign Technology, Inc. -0.34%563.216.4%$380.46m
BDXBecton, Dickinson & Co. -0.39%245.091.0%$343.43m
SYKStryker Corp. -0.35%245.761.3%$320.80m
DXCMDexCom, Inc. -1.20%391.917.8%$307.03m
IDXXIDEXX Laboratories, Inc. -1.62%529.473.8%$276.50m
BAXBaxter International, Inc. -0.37%77.651.8%$240.63m
ZBHZimmer Biomet Holdings, Inc. -1.19%161.461.7%$226.59m
EWEdwards Lifesciences Corp. 0.57%86.260.4%$219.41m
INOInovio Pharmaceuticals, Inc. -13.62%10.024.8%$212.43m

Company Profile

Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.